Skip to content

Non-Helium Magnetoencephalography in Autism Spectrum Disorder

Non-Helium Magnetoencephalography for Identifying Neurobiological Features and Functional Biomarkers in Children With Autism Spectrum Disorder: An Observational Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07064967
Enrollment
80
Registered
2025-07-15
Start date
2024-11-05
Completion date
2027-12-31
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder (ASD)

Keywords

Autism Spectrum Disorder, Magnetoencephalography

Brief summary

The goal of this observational study is to learn how brain activity in children with autism spectrum disorder (ASD) differs from typical developing children using magnetoencephalography (MEG). The main questions this study aims to answer are: Do children with ASD show different patterns of neural oscillation compared to typically developing children? Can MEG identify specific brain features that help ASD diagnosis? Participants will undergo MEG scan in both resting and tasking state, and their brain activity will be analyzed for characteristic neural oscillations and connectivity patterns. This study may help develop better tools for early ASD diagnosis.

Interventions

DIAGNOSTIC_TESTMagnetoencephalography

Participants will undergo magnetoencephalography scan in both resting and tasking state.

Sponsors

Beijing X-Magtech Technology Limited
CollaboratorUNKNOWN
Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
6 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Boys aged 6 to 12 years; * Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria; * Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test); * Sufficient compliance to participate in MEG experiments.

Exclusion criteria

* Comorbid neurological disorders, genetic syndromes, or severe developmental disabilities; * Metallic implants that may interfere with MEG signal acquisition; * Current use of antipsychotic medications or sedatives.

Design outcomes

Primary

MeasureTime frameDescription
Identification of Neural Oscillation Characteristics in Children with Autism Spectrum DisorderBaseline assessment (single time point, within 1 week of enrollment).The primary outcome will measure group differences in neural oscillation features (e.g., spectral power and spatial distribution) across frequency bands (alpha, beta, gamma) between children with Autism Spectrum Disorder and typically developing children during resting-state and task-based conditions. Quantified using time-frequency analysis of magnetoencephalography data. Statistical analysis will include independent t-tests (or Mann-Whitney U tests for non-normally distributed data) with false discovery rate (FDR) correction, using SPSS version 27.0.

Countries

China

Contacts

Primary ContactYe Song, Medical Doctor
15625984282@163.com+86-020-81886332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026